1st Line Head to Head Trials
Study
Phase
Treatment
Results/estimated primary completion
date
LUX-Lung 7
IIb
Afatinib vs gefitinib
Published (Park et al. 2016)
ARCHER 1050
III
Dacomitinib vs gefitinib
December 2016
SOLAR3
III
ASP8273 vs gefitinib or erlotinib
May 2019
FLAURA
III
AZD9291 (osimertinib) vs gefitinib or
erlotinib
August 2017
SWOG S14035
II/III
Afatinib vs afatinib-cetuximab
February 2020
RELAY
III
Erlotinib vs erlotinib-ramucirumab
September 2017
Park K, et al. Lancet Oncol 2016;17:577–89; and ClinicalTrials.gov..
